The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Bestatin, an inhibitor of aminopeptidase B, produced by actinomycetes.
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A THERMOLYSIN INHIBITOR PRODUCED BY ACTINOMYCETES: PHOSPHORAMIDON
SUDA, H., AOYAGI, T., TAKEUCHI, T., & UMEZAWA, H. (1973) · The Journal of Antibiotics · doi:10.7164/antibiotics.26.621 · Cited by 185
Self-citation
Cited by
Induced protein degradation: an emerging drug discovery paradigm
Lai, A. C., & Crews, C. M. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.211 · Cited by 1,486
Advancing targeted protein degradation for cancer therapy
Dale, B., Cheng, M., Park, K.-S., Kaniskan, H. Ü., Xiong, Y., & Jin, J. (2021) · Nature Reviews Cancer · doi:10.1038/s41568-021-00365-x · Cited by 632
HaloPROTACS: Use of Small Molecule PROTACs to Induce Degradation of HaloTag Fusion Proteins
Buckley, D. L., Raina, K., Darricarrere, N., Hines, J., Gustafson, J. L., Smith, I. E., Miah, A. H., Harling, J. D., & Crews, C. M. (2015) · ACS Chemical Biology · doi:10.1021/acschembio.5b00442 · Cited by 488
“commonly used as an aminopeptidase inhibitor, which can lead to off-target effects.(18) Furthermore, ligands for IAPs often induce degradation of the E3 ligase itself, (20), (an effect observed with some bestatin hybrids)(16) that complicates”
BackgroundBoron Containing Compounds as Protease Inhibitors
Smoum, R., Rubinstein, A., Dembitsky, V. M., & Srebnik, M. (2012) · Chemical Reviews · doi:10.1021/cr608202m · Cited by 450
A Chemoproteomic Approach to Query the Degradable Kinome Using a Multi-kinase Degrader
Huang, H.-T., Dobrovolsky, D., Paulk, J., Yang, G., Weisberg, E. L., Doctor, Z. M., Buckley, D. L., Cho, J.-H., Ko, E., Jang, J., et al. (2018) · Cell Chemical Biology · doi:10.1016/j.chembiol.2017.10.005 · Cited by 437
Targeted Protein Degradation: from Chemical Biology to Drug Discovery
Cromm, P. M., & Crews, C. M. (2017) · Cell Chemical Biology · doi:10.1016/j.chembiol.2017.05.024 · Cited by 412
Natural Compounds as Next-Generation Herbicides
Dayan, F. E., & Duke, S. O. (2014) · PLANT PHYSIOLOGY · doi:10.1104/pp.114.239061 · Cited by 385
Schwartz, J.-C., Malfroy, B., & De La Baume, S. (1981) · Life Sciences · doi:10.1016/0024-3205(81)90182-x · Cited by 381
Metalloaminopeptidases: Common Functional Themes in Disparate Structural Surroundings
Lowther, W. T., & Matthews, B. W. (2002) · Chemical Reviews · doi:10.1021/cr0101757 · Cited by 350
Klimpel, K. R., Arora, N., & Leppla, S. H. (1994) · Molecular Microbiology · doi:10.1111/j.1365-2958.1994.tb00500.x · Cited by 309
Regulatory role of brain angiotensins in the control of physiological and behavioral responses
Wright, J. W., & Harding, J. W. (1992) · Brain Research Reviews · doi:10.1016/0165-0173(92)90018-h · Cited by 276
Targeting Metalloenzymes for Therapeutic Intervention
Chen, A. Y., Adamek, R. N., Dick, B. L., Credille, C. V., Morrison, C. N., & Cohen, S. M. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00201 · Cited by 270
Bauvois, B., & Dauzonne, D. (2006) · Medicinal Research Reviews · doi:10.1002/med.20044 · Cited by 266
Positioning of aminopeptidase inhibitors in next generation cancer therapy
Hitzerd, S. M., Verbrugge, S. E., Ossenkoppele, G., Jansen, G., & Peters, G. J. (2014) · Amino Acids · doi:10.1007/s00726-013-1648-0 · Cited by 95
Stabilization and Inhibition of Protein–Protein Interactions: The 14-3-3 Case Study
Milroy, L.-G., Brunsveld, L., & Ottmann, C. (2013) · ACS Chemical Biology · doi:10.1021/cb300599t · Cited by 88
The analgesic activity of Bestatin as a potent APN inhibitor
Jia, M.-R. (2010) · Frontiers in Neuroscience · doi:10.3389/fnins.2010.00050 · Cited by 19
(1997) · PubMed · Cited by 15
Metadata
- Authors
- UMEZAWA, H., AOYAGI, T., SUDA, H., HAMADA, M., & TAKEUCHI, T.
- Venue
- The Journal of Antibiotics
- Published
- 1976
- Volume
- 29
- Issue
- 1
- Pages
- 97-99
- ISSN
- 0021-8820 (ISSN-L)
- 1881-1469
- OpenAlex
- W2002146198
- Cited by
- 722
- References
- 1
- FWCI
- 6.05
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.